Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 26, 2010
Mon, October 25, 2010 COWI, SGCA, RVXCF, LGCU, ONTY, MELA Have Been Added To Naked Short Lists Today
October 25, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold lists. Coroware (OTCBB: COWI), Strategic American Oil Corp (OTCBB: SGCA), ResverLogix Corp (OTC: RVXCF), Luna Gold (OTC: LGCU), Oncothyreon (NASDAQ: ONTY) and MELA Sciences (NASDAQ: MELA). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
CoroWare, Inc. (OTCBB: COWI) operates as a software professional services company with a focus on information technology integration and robotics integration, business automation solutions, and unmanned systems solutions in North America and Europe. It engages in the deployment and integration of computing platforms and applications, as well as development of unmanned vehicle software and solutions for customers in the research, commercial, and homeland security market segments. The company also provides release management, software systems development, and product integration services that help its customers to deliver quality products, solutions, and services; and enterprise business solutions, such as service oriented business applications, knowledge management and collaboration portals, and delivering solutions around a set of Microsoft products. In addition, it offers product realization, robotics simulation, systems architecture and design, and robotic applications development services; and CoroBot, a mobile robot for researchers, hobbyists, and developers in the industrial and service robot segments. The company serves customers in software development, information technology, education, homeland security, military defense, and automotive industry sectors. It was formerly known as Innova Robotics & Automation, Inc. and changed its name to CoroWare, Inc. in April 2008. The company was founded in 2003 and is based in Redmond, Washington. There is a failure to deliver in shares of COWI.
Strategic American Oil Corporation (OTCBB: SGCA), a natural resource exploration and production company, engages in the exploration, acquisition, and development of oil and gas properties in the United States. The company holds exploration properties in Texas, Louisiana, Oklahoma, and Illinois. As of July 31, 2009, it held interests in approximately 395 acres of gross developed and 14,297 acres of gross undeveloped land. The company was formerly known as Gulf States Energy, Inc. and changed its name to Strategic American Oil Corporation in September 2006. Strategic American Oil Corporation was founded in 2005 and is based in Corpus Christi, Texas. There is a failure to deliver in shares of SGCA.
Resverlogix Corporation (OTC: RVXCF), a biopharmaceutical company, focuses on the development of novel therapeutics in cardiovascular diseases, as well as in related indications in vascular inflammation and Alzheimer's disease. Its development programs include NexVas Plaque Regression, a technology platform, which has completed a Phase Ia safety trial in humans with RVX-208 and progressed to a Phase Ib/IIa clinical trial for the development of drugs that increase ApoA-I to reduce the risk of cardiovascular diseases; NexVas Vascular Inflammation, a discovery stage technology that is in preclinical stages for the development of drugs that target molecular markers of inflammation; NexVas Alzheimer's Disease, a discovery stage technology, which is in Phase I clinical trials for the development of drugs that enhance ApoA-I for the stabilization and regression of Beta Amyloid Plaque; ReVas, a research stage technology for the development of therapeutics to be used with medical devices for the treatment of cardiovascular diseases; and TGF- Shield, a preclinical stage therapeutic for the treatment of grievous proliferative diseases, such as cancer and fibrotic conditions. The company is headquartered in Calgary, Canada. There is a failure to deliver in shares of RVXCF.
Luna Gold Corp. (OTC: LGCU) engages in the acquisition, exploration, and development of gold properties in Brazil. It primarily has interests in the Aurizona Main project in Maranhao, Brazil, as well as in the Cachoeira project located in the state of Para. The company was formerly known as wwbroadcast.net, inc. and changed its name to Luna Gold Corp. in August 2003. Luna Gold Corp. was incorporated in 1986 and is headquartered in Vancouver, Canada. There is a failure to deliver in shares of LGCU.
Oncothyreon Inc. (NASDAQ: ONTY), a clinical-stage biopharmaceutical company, focuses primarily on the development of therapeutic products for the treatment of cancer. Its product under development includes ONT-10, a synthetic MUC1-based liposomal glycolipopeptide cancer vaccine for use in various cancer indications, including breast, thyroid, colon, stomach, pancreas, and prostate, as well as in certain types of lung cancer. The company is also developing small molecule drugs, such as PX-866, a Phase I trial product for the patients with advanced metastatic cancer; and PX-478 that completed enrollment in a Phase I trial for the patients with advanced metastatic cancer. It operates in Canada, the United States, Barbados, and Europe. The company was founded in 1985 and is headquartered in Seattle, Washington. There is a failure to deliver in shares of ONTY.
MELA Sciences, Inc. (NASDAQ: MELA) operates as a medical device company that focuses on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The companya�s principal product, MelaFind, features a hand-held imaging device that emits multiple wavelengths of light to capture images of suspicious pigmented skin lesions and extract data. This product uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma. It consists of hand-held imaging device, which employs high precision optics and multi-spectral illumination; database of pigmented skin lesions; and lesion classifiers, which are mathematical algorithms that extract lesion feature information and classify lesions. MELA Sciences filed the MelaFind pre-market approval application with the U.S. Food and Drug Administration (FDA) in June 2009 and is under review at the FDA. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences was founded in 1989 and is based in Irvington, New York. There is a failure to deliver in shares of MELA.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net
- WOPRAI
- support@woprai.com